Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials

Camilla Molich Hoff, Pernille Lassen, Jesper Grau Eriksen, Hanne Sand Hansen, Lena Specht, Marie Overgaard, Cai Grau, Jørgen Johansen, Jens Knud Daugaard Bentzen, Lisbeth Andersen, Jan F Evensen, Jens Overgaard

Research output: Contribution to journalJournal articleResearchpeer-review

49 Citations (Scopus)

Abstract

Patients with head and neck squamous cell carcinoma (HNSCC) and a low level of hemoglobin often have a poor response to radiation that may be related to hypoxia-induced radioresistance. We have previously published the importance of hemoglobin level and the effect of transfusion by the results from the randomized DAHANCA 5 trial, including 414 patients in the analysis. Aim of the current analysis was to gain additional power by adding patients from the continued subrandomization in the DAHANCA 7 trial, now including a total of almost 1200 patients.
Original languageEnglish
JournalActa Oncologica
Volume50
Pages (from-to)1006-14
Number of pages9
ISSN0284-186X
DOIs
Publication statusPublished - 2011
Externally publishedYes

Keywords

  • Adult
  • Aged
  • Carcinoma, Squamous Cell
  • Combined Modality Therapy
  • Erythrocyte Transfusion
  • Female
  • Head and Neck Neoplasms
  • Hemoglobins
  • Humans
  • Male
  • Middle Aged
  • Nimorazole
  • Radiotherapy
  • Survival Analysis

Fingerprint

Dive into the research topics of 'Does transfusion improve the outcome for HNSCC patients treated with radiotherapy? - results from the randomized DAHANCA 5 and 7 trials'. Together they form a unique fingerprint.

Cite this